A prospective feasibility study evaluating the 5x-multiplier to standardize discharge prescriptions in cancer surgery patients

التفاصيل البيبلوغرافية
العنوان: A prospective feasibility study evaluating the 5x-multiplier to standardize discharge prescriptions in cancer surgery patients
المؤلفون: DiPeri, Timothy P., Newhook, Timothy E., Day, Ryan W., Chiang, Yi-Ju, Dewhurst, Whitney L., Arvide, Elsa M., Bruno, Morgan L., Scally, Christopher P., Roland, Christina L., Katz, Matthew H.G., Vauthey, Jean-Nicolas, Chang, George J., Badgwell, Brian D., Perrier, Nancy D., Grubbs, Elizabeth G., Lee, Jeffrey E., Tzeng, Ching-Wei D., Bednarski, Brian K., Chen, Iris B., Comeaux, Ryan J., Cox, Dana M., Feig, Barry W., Fisher, Sarah B., Fournier, Keith F., Ghebremichael, Semhar J., Gibson, Heather M., Gourmelon, Nicole C., Graham, Paul H., Hancher, Shannon, Hunt, Kelly K., Ikoma, Naruhiko, Ivey MPAS, Shanae L., Keung, Emily Z., Ledet, Celia R., Limmer, Angela R., Mansfield, Paul F., Mayon, Lauren K., Messick, Craig A., Popat, Keyuri U., Rajkot MPAS, Nikita F., Robinson MPAS, Justine L., Robinson MPAS, Kristen A., Rodriguez-Bigas, Miguel A., Santos, David A., Skibber, John M., Speer, B. Bryce, Soliz, Jose, Tillman, Matthew M., Torres, Keila E., van Meter, Antoinette, Weldon, Marla E., Williams, Uduak Ursula, You, Y. Nancy
المصدر: Surgery Open Science; July 2022, Vol. 9 Issue: 1 p51-57, 7p
مستخلص: We designed a prospective feasibility study to assess the 5x-multiplier (5x) calculation (eg, 3 pills in last 24 hours × 5 = 15) to standardize discharge opioid prescriptions compared to usual care.
قاعدة البيانات: Supplemental Index
الوصف
تدمد:25898450
DOI:10.1016/j.sopen.2022.04.004